Gross Profit - NuVasive Inc (F:NK8) - Alpha Spread
N

NuVasive Inc
F:NK8

Watchlist Manager
NuVasive Inc
F:NK8
Watchlist
Price: 36.8 EUR Market Closed
Market Cap: 1.9B EUR
Have any thoughts about
NuVasive Inc?
Write Note

NuVasive Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NuVasive Inc
Gross Profit Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
N
NuVasive Inc
F:NK8
Gross Profit
$878.7m
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
6%
Becton Dickinson and Co
NYSE:BDX
Gross Profit
$9B
CAGR 3-Years
4%
CAGR 5-Years
2%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$10.5B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Gross Profit
$13.7B
CAGR 3-Years
9%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Gross Profit
$22.6B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$5.1B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

See Also

What is NuVasive Inc's Gross Profit?
Gross Profit
878.7m USD

Based on the financial report for Jun 30, 2023, NuVasive Inc's Gross Profit amounts to 878.7m USD.

What is NuVasive Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
6%

Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for NuVasive Inc have been 5% over the past three years , 3% over the past five years , and 6% over the past ten years .

Back to Top